Introduction {#sec1-1}
============

Intraventricular hemorrhage (IVH) is a devastating neurosurgical entity commonly seen in cases involving hypertensive intracerebral hemorrhage (ICH) with extension into the ventricular system. Approximately, 10%--15% of ICH cases involve thalamic hemorrhage.\[[@ref1]\]

Evacuation of a thalamic hematoma via craniotomy is generally considered controversial because of the high rates of mortality and morbidity associated with this procedure. Thalamic hemorrhages are clinically significant, as they are located close to the internal capsule and ventricular system. However, with the evolution of the neuroendoscope and hemostatic agents, the surgical evacuation deep-seated ICHs is now safer and less invasive than before.

Many studies had found that ICH volume, IVH, hydrocephalus, Glasgow Coma Scale (GCS) score, and age are the best predictors of mortality and functional outcome after thalamic ICH.\[[@ref2]\]

Traditional working-channel endoscopic surgery, a less invasive, alternative procedure, is relatively inefficient for evacuating a hematoma because of limited visualization of the surgical field and manipulation of surgical instruments through the working channel.\[[@ref3]\] IVH caused by thalamic hemorrhage is generally treated with external ventricular drainage (EVD).\[[@ref4][@ref5]\] The endoscopic approach for the evacuation of an IVH and thalamic hemorrhage led to promising results with respect to the prevention of aspiration-related pneumonia, which needs antibiotic treatment, and shunt-dependent hydrocephalus. The aim of this study was to investigate the efficacy and compare the results of endoscopic surgery for the evacuation of a thalamic and intraventricular hematoma against those of EVD surgery.

Materials and Methods {#sec1-2}
=====================

From January 2012 to December 2018, 38 patients with IVH caused by thalamic hemorrhage were treated in our department. Details regarding the study protocol, randomization, and surgical procedure were explained to close family members. Once they fully understood the study, informed consent was obtained. Our study was approved by the Institutional Ethics Committee. Randomization was accomplished using sealed envelopes containing the type of treatment. The envelopes were initially blinded to the consenting individuals and the surgeon. The selected patients were randomly divided into two groups: an EVD group and an EVD, endoscopic surgery group. Patients with thalamic hemorrhage not associated with IVH or secondary parenchymal hemorrhage were excluded. This study had a prospective and randomized design.

Operation {#sec2-1}
---------

In the EVD and endoscopic surgery group, the procedure was performed with the patient in a supine position under general anesthesia. A 4-cm incision was made in the frontal scalp, ipsilateral to the thalamic hematoma. A burr hole (1 cm in diameter) was drilled 11 cm upward, 3 cm outside from nasion. A transcortical transventricular puncture was made with a 7-mm rigid endoscope sheath. When the ventricle was reached, the stylet was removed and a 2.7-mm, 0° endoscope (Storz) and a suction tube were inserted through this tube, permitting the simultaneous removal of intraventricular and thalamic hematomas.\[[@ref6]\] ARTCEREB^®^ (Otsuka, 37°C--38°C) was used for irrigation until the intraventricular structures were fairly visible. When a bleeding vessel was encountered, the suction tube was replaced with a 3-mm unipolar suction, coagulation tube to cauterize the vessel. No intraventricular injection of an anticoagulant was administered during the procedure. Once the endoscopic procedure was completed, an external ventricular drain was placed. In the EVD group, a traditional EVD insertion was performed. An incision measuring 3 cm was made 11 cm upward, 3 cm outside from nasion, on the side with the least amount of blood in the lateral ventricle. Patients with ventricular blood received continuous drainage until there was no further reduction in cerebrospinal fluid (CSF) blood content. The EVD catheter was then sequentially weaned in daily increments of 5-cm H~2~O and removed. Patients were considered for permanent ventriculoperitoneal (VP) shunt surgery if they developed hydrocephalus. In both groups, the EVD was placed at an initial height of 12 cm from the tragus.

Clinical evaluation {#sec2-2}
-------------------

The clinical evaluation data included the GCS score, age, ICH volume, and IVH severity. The ICH volume was calculated using the simplified equation 1/2A + B + C, where A is the maximum width measured, B is the length, and C is the height.\[[@ref7]\] Initial IVH severity was graded according to the amount of blood in each ventricle using Graeb scores from 0 to 12, which represents the sum of the score in each ventricle, 4 is the maximum in each lateral ventricle and 2 is the maximum in the third and fourth ventricles.\[[@ref8][@ref6]\] The clinical data of the patients with thalamic ICH with IVH are listed in [Table 1](#T1){ref-type="table"}.

###### 

Clinical data of patients

                EVD (*n*=30)   EVD + endoscopic (*n*=38)   *P*
  ------------- -------------- --------------------------- ------
  Age           70.6           69.8                        0.41
  GCS           8.05           7.59                        0.32
  ICH volume    26.9           27.1                        0.45
  Graeb score   5.74           6.17                        0.3

EVD -- External ventricular drainage; GCS -- Glasgow Coma Scale; ICH -- Intracerebral hemorrhage

Outcome analysis {#sec2-3}
----------------

Patient function was evaluated using the Glasgow Outcome Scale (GOS) score. The 30-day mortality rate, 30-day pneumonia-onset rates, and 30-day VP shunt dependency rates were also evaluated.

Statistical analysis {#sec2-4}
--------------------

Data entry and analysis were done using an SPSS Statistics (Version 20.0; SPSS, IBM Corporation, Chicago, United States). For continuous variables with or without equal variances, independent *t*-tests were used to investigate differences between subsets of patients classified by categorical data. Variables with *P* \< 0.05 were considered to be statistically significant.

Illustrative case {#sec2-5}
-----------------

A 65-year-old male was admitted to our hospital because of left hemiparesis and disturbance of consciousness. At the time of admission, he was drowsy (GCS score 7). Computed tomography (CT) revealed a right-sided thalamic hemorrhage with a rupture into the ventricle and acute hydrocephalus \[[Figure 1a](#F1){ref-type="fig"}\]. The volume of the hematoma was estimated to be 60 mL. The patient was intubated and underwent endoscopic surgery to evacuate the hematoma. Postoperative CT revealed complete removal of the thalamic hematoma \[[Figure 1b](#F1){ref-type="fig"}\]. A ventricular drain was kept in lateral ventricle for 1 week after the operation. He regained consciousness 1 week later but displayed the left-sided hemiparesis. However, after 3 months, she had a GOS score of 3.

![(a) Preoperative computed tomography reveals right thalamic hemorrhage and rupture into ventricles. (b) Postoperative computed tomography reveals complete evacuation of the thalamic hematoma](AJNS-14-1112-g001){#F1}

Results {#sec1-3}
=======

All the patients in this study had hypertensive hemorrhage. These patients were randomly divided into an EVD group and an endoscopic surgery group. The clinical features of each group are shown in [Table 1](#T1){ref-type="table"}. Twenty patients were managed with endoscopic surgery and 18 with EVD. Their ages ranged from 49 to 88 years, with a mean age of 70.6 years. There were 14 male and 6 female patients. On admission, the patients' clinical conditions were evaluated using the GCS score. No significant differences in age were found between the two groups. There was no significant difference in ICH volume or Graeb score between the endoscopic group and the EVD group.

The mean GOS score was 3.38 in the endoscopic surgery group and 2.75 in the EVD group. Brain CT was performed pre- and postoperatively to assess the severity of the thalamic and IVH and its grading based on the Graeb scoring system. The mean length of hospitalization was 35.8 days in the endoscopic surgery group and 43.5 days in the EVD group.

The endoscopic surgery shortened administration for about 1 week. Pneumonia onset rate until 30 days after hospitalization was 11.1% in the endoscopic surgery group and 45.0% in the EVD group.

When the outcome was significantly correlated with the severity of thalamic hematoma and pneumonia onset rate, it was observed that the IVH severity did not influence the outcome. There was no significant difference in mortality rate between the endoscopic group and EVD group.

The drainage dependency 3 months postprocedurally was much lower in patients treated with endoscopic surgery. At 3 months, the drainage dependency was 27.8% in patients treated with endoscopic surgery as compared to 60.0% in patients treated with EVD \[[Table 2](#T2){ref-type="table"}\]. None of the patients who underwent endoscopic surgery experienced rebleeding events.

###### 

Result of patients after treatment

                               EVD (*n*=30)   EVD + endoscopic (*n*=38)   *P*
  ---------------------------- -------------- --------------------------- ---------
  30 days mortality rate (%)   15             5.6                         0.31
  30 days pneumonia rate (%)   45             11                          0.02
  GOS                          2.75           3.38                        0.03
  Shunt dependent rate (%)     60             27.8                        0.00013
  Hospitalization (day)        43.5           35.8                        0.011

EVD -- External ventricular drainage; GOS -- Glasgow Outcome Scale

We classified endoscopic surgery group by ICH evacuation rate \[[Table 3](#T3){ref-type="table"}\]. Group A was 0%--80% evacuation rate and B was 80%--100%. Group B was lower shunt-dependent rate (*P* = 0.04) and shorter hospitalization (*P* = 0.026).

###### 

Result of each intracerebral hemorrhage evacuation rate

  ICH evacuation rate    GOS (*n*=38)   Shunt-dependent rate (*n*=38)   Hospitalization (*n*=38)
  ---------------------- -------------- ------------------------------- --------------------------
  A: 0%-80% (*n*=7)      3              57.1                            41.3
  B: 80%-100% (*n*=31)   3.5            19.3                            33.8
  *P*                    0.12           0.04                            0.026

GOS -- Glasgow Outcome Scale

Discussion {#sec1-4}
==========

A thalamic ICH was seen in 10%--15% of all cases of ICH,\[[@ref6]\] which is a severe clinical condition with an in-hospital mortality rate ranging from 12% to 37%\[[@ref9]\] and may even be 52% in cases involving ventricular extensive hemorrhage. Altered consciousness, IVH, hydrocephalus, ICH volume, and advanced age were independent predictors of in-hospital mortality in patients with thalamic hemorrhage.\[[@ref2]\] IVH has been found to be a strong predictor of in-hospital mortality in some studies,\[[@ref10]\] and IVH should be prioritized for treatment in cases involving thalamic hematomas with ventricular extension. The mortality rate of thalamic hemorrhage is reportedly 12% after 6 ± 6 days since stroke and 17.3% within 6 months as per Mori *et al*\'s\[[@ref11]\] series. In Chung *et al*\'s\[[@ref9]\] series, the case fatality was 37% at the time of discharge. Steinke *et al.*\[[@ref1]\] found that in-hospital mortality occurred in 52% of thalamic hematomas with ventricular extension and that intraventricular extension is a powerful independent predictor of mortality.

The current standard management strategy for massive thalamic IVH involves the placement of an EVD catheter. However, this procedure addresses only the sequelae of hydrocephalus and increased intracranial pressure (ICP). To address these devastating clinical sequelae caused by thalamic and IVH, various authors have studied the use of neuroendoscopic surgery.\[[@ref12]\] The purpose of this study was to explore a method of managing massive intraventricular and thalamic hemorrhage, which is minimally invasive and simultaneously provides maximal clinical benefit. In our study, the addition of endoscopic surgery for thalamic hemorrhage prevented pneumonia, reduced shunt dependency, and improved the neurologic symptoms earlier than EVD only.

Blood clots within the ventricular system lead to acute obstruction of the CSF and a sudden rise in ICP. As the clot within the ventricular system undergoes lysis, the fibrin degradation products (FDPs) and bilirubin oxidation products (BOx) that are formed during the breakdown process enter and circulate in the CSF. FDPs and BOx then reach the arachnoid granulation and cause delayed communicating hydrocephalus.\[[@ref13]\]

This causes obstruction of normal CSF flow and acute hydrocephalus. EVD was frequently used for the relief of hydrocephalus. Hydrocephalus is associated with poor outcomes, and shunt surgery is hampered by several problems including obstruction, infection, and malfunction.\[[@ref14]\]

Our study showed that endoscopic surgery can decrease the incidence of shunt dependent hydrocephalus caused by thalamic hemorrhage from 60.0% to 27.8%. This may be due to the fact that endoscopic surgery can remove intraventricular and thalamic hemorrhage and also rapidly reverse ventricular dilatation and normalize ICP.

In general, as for thalamic bleeding, conservative treatment or drainage is chosen. Our study revealed that the minimally invasive endoscopic procedure for the evacuation of the thalamic hematoma helped prevent pneumonia and improved the GOS score while decreasing shunt dependency. Endoscopic surgery for thalamic bleeding with IVH has the potential to become the first-choice treatment.

Conclusions {#sec1-5}
===========

The use of neuroendoscopy in patients with a massive IVH and thalamic hemorrhage significantly reduced drainage dependency and resulted in good clinical outcomes. This may be related to the early removal of the thalamus and intraventricular hematomas. Our study revealed a potentially better functional outcome through neuroendoscopy with considerable advantages in the hospitalization and shunt dependency.
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